Best Practices for Medical Device Regulatory Due Diligence

A discussion of key FDA and EU/UK considerations when conducting due diligence on medical device companies, including:

• Factors that can impact the scope of regulatory due diligence
• Specific diligence considerations for pre-commercial targets and targets with commercialized products
• Recommended post-diligence activities

Presenters

• Sarah Cowlishaw, Partner
• Pamela Forrest, Partner

Event Details

Tuesday, January 20, 2026
10:00 - 11:00 a.m. ET
3:00 - 4:00 p.m. GMT

Log-in details will be provided upon registration.

This event is closed to the press.

CLE - This program is currently under review for Continuing Legal Education (CLE) credit in California and New York (for both newly admitted and experienced attorneys). Approval is pending, and participants will be notified once a determination has been made.